Oragenics (OGEN)
(Delayed Data from AMEX)
$1.32 USD
+0.06 (4.76%)
Updated Aug 5, 2025 03:54 PM ET
After-Market: $1.31 -0.01 (-0.76%) 5:42 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Oragenics, Inc. has a market cap of $1.04M, which represents its share price of $1.26 multiplied by its outstanding shares number of 0.82M. As a small-cap company, OGEN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
OGEN 1.32 +0.06(4.76%)
Will OGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for OGEN
Oragenics (OGEN) Selects CRO for Phase IIa Trial of Concussion Drug
Oragenics selects South Star Research as its CRO for ONP-002 Phase IIa trial
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase ...
Oragenics (OGEN) Secures Manufacturing Deal for Key Drug Candidate | OGEN Stock News
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical ...